BALAXI
Invest Now
Start SIP in
BALAXI
Performance
- Low
- ₹54
- High
- ₹57
- 52 Week Low
- ₹50
- 52 Week High
- ₹151
- Open Price₹55
- Previous Close₹55
- Volume83,459
Investment Returns
- Over 1 Month -18.3%
- Over 3 Month -22.51%
- Over 6 Month -39.85%
- Over 1 Year -55.25%
Smart Investing Starts Here Start SIP with Balaxi Pharmaceuticals for Steady Growth!
Balaxi Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 11
- PEG Ratio
- 0
- Market Cap Cr
- 302
- P/B Ratio
- 1.4
- Average True Range
- 3.72
- EPS
- 4.77
- Dividend Yield
- 0
- MACD Signal
- -1.16
- RSI
- 29.46
- MFI
- 15.78
Balaxi Pharmaceuticals Financials
Balaxi Pharmaceuticals Technicals
EMA & SMA
Current Price
₹54.63
-0.53
(-0.96%)

-
- Bearish Moving Average 16
-
- Bullish Moving Average 0
- 20 Day
- ₹62.20
- 50 Day
- ₹64.77
- 100 Day
- ₹70.15
- 200 Day
- ₹79.92
Resistance and Support
55.75
- R3 58.57
- R2 57.83
- R1 56.49
- S1 54.41
- S2 53.67
- S3 52.33
Balaxi Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-10 | Quarterly Results & Others | To consider other business matters. split from Rs. 10/- to Rs. 2/-. |
2024-11-05 | Quarterly Results & Others | To consider other business matters. split from Rs. 10/- to Rs. 2/-. |
2024-08-02 | Quarterly Results | |
2024-05-29 | Audited Results | |
2023-11-02 | Quarterly Results |
Balaxi Pharmaceuticals F&O
About Balaxi Pharmaceuticals
- NSE Symbol
- BALAXI
- BSE Symbol
- Managing Director
- Mr. Ashish Maheshwari
- ISIN
- INE618N01022
Similar Stocks to Balaxi Pharmaceuticals
Balaxi Pharmaceuticals FAQs
Balaxi Pharmaceuticals share price is ₹54 As on 02 May, 2025 | 19:18
The Market Cap of Balaxi Pharmaceuticals is ₹301.6 Cr As on 02 May, 2025 | 19:18
The P/E ratio of Balaxi Pharmaceuticals is 11 As on 02 May, 2025 | 19:18
The PB ratio of Balaxi Pharmaceuticals is 1.4 As on 02 May, 2025 | 19:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.